Skip to main content
Erschienen in: Pediatric Surgery International 1/2023

01.12.2023 | Original Article

Efficacy analysis of multidisciplinary treatment for Wilms tumor in a single center

verfasst von: Fengming Ji, Chengchuang Wu, Ye Li, Chenghao Zhanghuang, Jinrong Li, Li Li, Zhen Yang, Bing Yan

Erschienen in: Pediatric Surgery International | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To analyze the efficacy of multidisciplinary treatment for Wilms tumor (WT) in Kunming Children’s Hospital, and investigate the risk factors affecting the prognosis of WT.

Methods

The clinic-pathological data were collected and analyzed in patients with unilateral WT treated in Kunming Children's Hospital from January 2017 to July 2021. Research subjects were selected according to inclusion criteria and exclusion criteria. The risk factors and independent risk factors that affect the prognosis of patients with WT were determined by Kaplan–Meier survival analysis and Cox proportional hazards model, respectively.

Outcome

A total of 68 children were included in this study, and the 5-year overall survival (OS) rate was 87.4%. Kaplan–Meier survival analysis results showed that ethnicity (P = 0.020), the tumor volume of resection (P = 0.001), histological type (P < 0.001), and postoperative recurrence (P < 0.001) were the risk factors affecting the prognosis of children with WT. The results of the Cox proportional hazards model showed that only the histological type (P = 0.018) was the independent risk factor for the prognosis of WT.

Conclusion

The efficacy of multidisciplinary treatment for WT was satisfying. The histological type has important predictive value for the prognosis of WT, and the patient with unfavorable histology has a poor prognosis.
Literatur
1.
Zurück zum Zitat Stokes CL, Stokes WA, Kalapurakal JA et al (2018) Timing of radiation therapy in pediatric Wilms tumor: a report from the national cancer database. Int J Radiat Oncol Biol Phys 101(2):453–461CrossRefPubMed Stokes CL, Stokes WA, Kalapurakal JA et al (2018) Timing of radiation therapy in pediatric Wilms tumor: a report from the national cancer database. Int J Radiat Oncol Biol Phys 101(2):453–461CrossRefPubMed
3.
Zurück zum Zitat Petiti J, Rosso V, Lo Iacono M et al (2018) Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia. Leuk Res 67:6–11CrossRefPubMed Petiti J, Rosso V, Lo Iacono M et al (2018) Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia. Leuk Res 67:6–11CrossRefPubMed
4.
Zurück zum Zitat Rakheja D, Khokhar S, Mitui M, Cost NG (2012) Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol 15(4):286–292CrossRefPubMed Rakheja D, Khokhar S, Mitui M, Cost NG (2012) Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol 15(4):286–292CrossRefPubMed
5.
Zurück zum Zitat Camp ND, James RG, Dawson DW et al (2012) Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein. J Biol Chem 287(9):6539–6550CrossRefPubMedPubMedCentral Camp ND, James RG, Dawson DW et al (2012) Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein. J Biol Chem 287(9):6539–6550CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hontecillas-Prieto L, García-Domínguez DJ, García-Mejías R, Ramírez-Villar GL, Sáez C, de Álava E (2017) HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients. Oncotarget 8(70):115290–115303CrossRefPubMedPubMedCentral Hontecillas-Prieto L, García-Domínguez DJ, García-Mejías R, Ramírez-Villar GL, Sáez C, de Álava E (2017) HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients. Oncotarget 8(70):115290–115303CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Nakata K, Colombet M, Stiller CA, Pritchard-Jones K, Steliarova-Foucher E (2020) IICC-3 Contributors. Incidence of childhood renal tumours: An international population-based study. Int J Cancer 147(12):3313–3327 Nakata K, Colombet M, Stiller CA, Pritchard-Jones K, Steliarova-Foucher E (2020) IICC-3 Contributors. Incidence of childhood renal tumours: An international population-based study. Int J Cancer 147(12):3313–3327
9.
Zurück zum Zitat Breslow N, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21(3):172–181CrossRefPubMed Breslow N, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21(3):172–181CrossRefPubMed
11.
Zurück zum Zitat Lopes RI, Lorenzo A (2017) Recent advances in the management of Wilms' tumor. F1000Res 6:670 Lopes RI, Lorenzo A (2017) Recent advances in the management of Wilms' tumor. F1000Res 6:670
12.
Zurück zum Zitat Nakamura L, Ritchey M (2010) Current management of Wilms’ tumor. Curr Urol Rep 11(1):58–65CrossRefPubMed Nakamura L, Ritchey M (2010) Current management of Wilms’ tumor. Curr Urol Rep 11(1):58–65CrossRefPubMed
13.
Zurück zum Zitat Vujanić GM, D’Hooghe E, Graf N et al (2021) Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms’ tumor: an analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. Int J Cancer 149(6):1332–1340CrossRefPubMed Vujanić GM, D’Hooghe E, Graf N et al (2021) Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms’ tumor: an analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies. Int J Cancer 149(6):1332–1340CrossRefPubMed
14.
Zurück zum Zitat Chiang KM, Tsay YC, Vincent Ng TC et al (2019) Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in Han Chinese. J Clin Med 8(8) Chiang KM, Tsay YC, Vincent Ng TC et al (2019) Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in Han Chinese. J Clin Med 8(8)
15.
Zurück zum Zitat Indorewalla KK, O’Connor MK, Budson AE, Guess DiTerlizzi C, Jackson J (2021) Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in Alzheimer’s disease research. J Alzheimers Dis 80(3):927–940CrossRefPubMedPubMedCentral Indorewalla KK, O’Connor MK, Budson AE, Guess DiTerlizzi C, Jackson J (2021) Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in Alzheimer’s disease research. J Alzheimers Dis 80(3):927–940CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bell CN, Thorpe RJ Jr, Bowie JV, LaVeist TA (2018) Race disparities in cardiovascular disease risk factors within socioeconomic status strata. Ann Epidemiol 28(3):147–152CrossRefPubMed Bell CN, Thorpe RJ Jr, Bowie JV, LaVeist TA (2018) Race disparities in cardiovascular disease risk factors within socioeconomic status strata. Ann Epidemiol 28(3):147–152CrossRefPubMed
17.
Zurück zum Zitat Pillay B, Wootten AC, Crowe H et al (2016) The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev 42:56–72CrossRefPubMed Pillay B, Wootten AC, Crowe H et al (2016) The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev 42:56–72CrossRefPubMed
18.
Zurück zum Zitat Li W, Hua RX, Wang M et al (2021) H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Mol Genet Genomic Med 9(2):e1584CrossRefPubMedPubMedCentral Li W, Hua RX, Wang M et al (2021) H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Mol Genet Genomic Med 9(2):e1584CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Nakata K, Williams R, Kinoshita Y et al (2021) Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan. Pediatr Blood Cancer 68(10):e29143CrossRefPubMed Nakata K, Williams R, Kinoshita Y et al (2021) Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan. Pediatr Blood Cancer 68(10):e29143CrossRefPubMed
20.
Zurück zum Zitat Cox S, Büyükünal C, Millar A (2020) Surgery for the complex Wilms tumour. Pediatr Surg Int 36(2):113–127CrossRefPubMed Cox S, Büyükünal C, Millar A (2020) Surgery for the complex Wilms tumour. Pediatr Surg Int 36(2):113–127CrossRefPubMed
21.
Zurück zum Zitat Zhang Y, Song HC, Yang YF, Sun N, Zhang WP, Huang CR (2021) Preoperative Wilms tumor rupture in children. Int Urol Nephrol 53(4):619–625CrossRefPubMed Zhang Y, Song HC, Yang YF, Sun N, Zhang WP, Huang CR (2021) Preoperative Wilms tumor rupture in children. Int Urol Nephrol 53(4):619–625CrossRefPubMed
22.
Zurück zum Zitat Junjun J, Xuelian Z, Dhruba K, Haiyang X, Lin Z, Shusen Z (2015) Efficacy of preoperative chemotherapy in treatment of children with Wilms’ tumor: a meta-analysis. Iran J Pediatr 25(2):e366CrossRefPubMedPubMedCentral Junjun J, Xuelian Z, Dhruba K, Haiyang X, Lin Z, Shusen Z (2015) Efficacy of preoperative chemotherapy in treatment of children with Wilms’ tumor: a meta-analysis. Iran J Pediatr 25(2):e366CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Groenendijk A, Spreafico F, de Krijger RR et al (2021) Prognostic factors for Wilms Tumor recurrence: a review of the literature. Cancers (Basel) 13(13) Groenendijk A, Spreafico F, de Krijger RR et al (2021) Prognostic factors for Wilms Tumor recurrence: a review of the literature. Cancers (Basel) 13(13)
24.
Zurück zum Zitat Powis M, Messahel B, Hobson R, Gornall P, Walker J, Pritchard-Jones K (2013) Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms’ tumour: findings from the 1991–2001 United Kingdom Children’s Cancer Study Group UKW3 Trial. J Pediatr Surg 48(11):2181–2186CrossRefPubMed Powis M, Messahel B, Hobson R, Gornall P, Walker J, Pritchard-Jones K (2013) Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms’ tumour: findings from the 1991–2001 United Kingdom Children’s Cancer Study Group UKW3 Trial. J Pediatr Surg 48(11):2181–2186CrossRefPubMed
25.
Zurück zum Zitat Graf N, Tournade MF, de Kraker J (2000) The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 27(3):443–54 Graf N, Tournade MF, de Kraker J (2000) The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 27(3):443–54
26.
Zurück zum Zitat Godzinski J, van Tinteren H, de Kraker J et al (2011) Nephroblastoma: does the decrease in tumor volume under preoperative chemotherapy predict the lymph nodes status at surgery. Pediatr Blood Cancer 57(7):1266–1269CrossRefPubMed Godzinski J, van Tinteren H, de Kraker J et al (2011) Nephroblastoma: does the decrease in tumor volume under preoperative chemotherapy predict the lymph nodes status at surgery. Pediatr Blood Cancer 57(7):1266–1269CrossRefPubMed
27.
Zurück zum Zitat Rutigliano DN, Kayton ML, Steinherz P, Wolden S, La Quaglia MP (2007) The use of preoperative chemotherapy in Wilms’ tumor with contained retroperitoneal rupture. J Pediatr Surg 42(9):1595–1599CrossRefPubMed Rutigliano DN, Kayton ML, Steinherz P, Wolden S, La Quaglia MP (2007) The use of preoperative chemotherapy in Wilms’ tumor with contained retroperitoneal rupture. J Pediatr Surg 42(9):1595–1599CrossRefPubMed
28.
Zurück zum Zitat Jain J, Sutton KS, Hong AL (2021) Progress update in pediatric renal tumors. Curr Oncol Rep 23(3):33CrossRefPubMed Jain J, Sutton KS, Hong AL (2021) Progress update in pediatric renal tumors. Curr Oncol Rep 23(3):33CrossRefPubMed
29.
Zurück zum Zitat Green DM, Beckwith JB, Breslow NE et al (1994) Treatment of children with stages II to IV anaplastic Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 12(10):2126–2131CrossRefPubMed Green DM, Beckwith JB, Breslow NE et al (1994) Treatment of children with stages II to IV anaplastic Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 12(10):2126–2131CrossRefPubMed
30.
Zurück zum Zitat Dome JS, Perlman EJ, Graf N (2014) Risk stratification for wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book 215–23 Dome JS, Perlman EJ, Graf N (2014) Risk stratification for wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book 215–23
31.
Zurück zum Zitat Vujanić GM, Gessler M, Ooms A et al (2018) The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol 15(11):693–701CrossRefPubMedPubMedCentral Vujanić GM, Gessler M, Ooms A et al (2018) The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol 15(11):693–701CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Dome JS, Cotton CA, Perlman EJ et al (2006) Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol 24(15):2352–2358CrossRefPubMed Dome JS, Cotton CA, Perlman EJ et al (2006) Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol 24(15):2352–2358CrossRefPubMed
33.
Zurück zum Zitat Vujanić GM, Harms D, Sandstedt B, Weirich A, de Kraker J, Delemarre JF (1999) New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol 32(5):317–323CrossRefPubMed Vujanić GM, Harms D, Sandstedt B, Weirich A, de Kraker J, Delemarre JF (1999) New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol 32(5):317–323CrossRefPubMed
34.
35.
Zurück zum Zitat Maschietto M, Williams RD, Chagtai T et al (2014) TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia. PLoS ONE 9(10):e109924CrossRefPubMedPubMedCentral Maschietto M, Williams RD, Chagtai T et al (2014) TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia. PLoS ONE 9(10):e109924CrossRefPubMedPubMedCentral
Metadaten
Titel
Efficacy analysis of multidisciplinary treatment for Wilms tumor in a single center
verfasst von
Fengming Ji
Chengchuang Wu
Ye Li
Chenghao Zhanghuang
Jinrong Li
Li Li
Zhen Yang
Bing Yan
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 1/2023
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-023-05408-y

Weitere Artikel der Ausgabe 1/2023

Pediatric Surgery International 1/2023 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.